BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7313357)

  • 1. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
    Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 4. [The hemodynamic effects of oral prazosine and intravenous nicergoline in heart failure (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Ourbak P; Maurice P
    Ann Cardiol Angeiol (Paris); 1980; 29(5):379-84. PubMed ID: 7425504
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prazosin in chronic refractory cardiac insufficiency: results of continuous long-term therapy].
    Sánchez Domínguez J; Villa JG; Urbina Fuentes FJ; Menéndez Lozano A
    Rev Clin Esp; 1981 Apr; 161(2):113-7. PubMed ID: 7280315
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Kuhn H; Boch H; Lösse B
    Z Kardiol; 1981 Jul; 70(7):501-7. PubMed ID: 7269730
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of long-term treatment with isosorbide dinitrate and prazosin in cardiac insufficiency].
    Franchi F; Michelucci A; Morace G; Porciani MC; Fantini F
    Clin Ter; 1980 Apr; 93(1):3-20. PubMed ID: 7449331
    [No Abstract]   [Full Text] [Related]  

  • 8. [Haemodynamic effects and plasma concentrations of prazosin in chronic heart failure (author's transl)].
    Pornin M; Decourt S; Sellier P; Guermonprez JL; Ourbak P; Maurice P; Flouvat B
    Therapie; 1981; 36(4):435-42. PubMed ID: 7292426
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
    Klein W; Goebel R
    Z Kardiol; 1980 Feb; 69(2):120-5. PubMed ID: 6779433
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Comşulea L; Streian C
    Med Interne; 1984; 22(1):29-33. PubMed ID: 6710045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of prazosin in chronic congestive heart failure].
    Bassand JP; Becque O; Berthout P; Vial Y; Magnin D; Bernard Y; Maurat JP
    Arch Mal Coeur Vaiss; 1980 Jun; 73(6):747-56. PubMed ID: 6779769
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
    Tomov I; Kaloianova A; Terzieva L; Elenkova A; Nikolov G
    Vutr Boles; 1981; 20(6):72-8. PubMed ID: 7039130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilator therapy--a physiologic approach to the treatment of heart failure.
    Braunwald E
    N Engl J Med; 1977 Aug; 297(6):331-3. PubMed ID: 876316
    [No Abstract]   [Full Text] [Related]  

  • 15. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 17. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
    Reyns PR; Romney D; Desser KB; Benchimol A
    Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effects and clinical observations on prazosin in treating chronic refractory congestive heart failure].
    Shen LH; Ku FS; Liu QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):244-7, 315. PubMed ID: 6544203
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
    Ogawa T; Sekiguchi T; Ishii M; Sugishita Y; Ito I
    Kokyu To Junkan; 1985 Feb; 33(2):171-7. PubMed ID: 4001595
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prazosin in the treatment of chronic cardiac failure (author's transl)].
    Lanfranchi J; Sachs RN
    Ann Cardiol Angeiol (Paris); 1982; 31(2):133-7. PubMed ID: 7049045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.